Machine Learning Models to Predict Cytochrome P450 2B6 Inhibitors and Substrates
Chemical Research in Toxicology · 2023
DOI: 10.1021/acs.chemrestox.3c00065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2023. Verfasst von Longqiang Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East…. Hauptthemen laut MEDLINE: Cytochrome P-450 Enzyme System, Cytochrome P-450 CYP2B6 Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Shanghai Municipal Education Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cytochrome P450 2B6 (CYP2B6) is responsible for the metabolism of ∼7% of marketed drugs. The in vitro drug interaction studies guidance for industry issued by the FDA stipulates that drug sponsors need to evaluate whether the investigated drugs interact with the major drug-metabolizing P450s including CYP2B6. Therefore, there has been greater attention to the development of predictive models for CYP2B6 inhibitors and substrates. In this study, conventional machine learning and deep learning models were developed to predict CYP2B6 inhibitors and substrates. Our results showed that the best CYP2B6 inhibitor model yielded the AUC values of 0.95 and 0.75 with the 10-fold cross-validation and the test set, respectively, and the best CYP2B6 substrate model produced the AUC values of 0.93 and 0.90 with the 10-fold cross-validation and the test set, respectively. The generalization ability of the CYP2B6 inhibitor and substrate models was assessed by using the external validation sets. Several significant substructural fragments relevant to CYP2B6 inhibitors and substrates were detected via frequency substructure analysis and information gain. In addition, the applicability domain of the models was defined by employing a nonparametric method based on the probability density distribution. We anticipate that our results would be useful for the prediction of potential CYP2B6 inhibitors and substrates in the early stage of drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shangha…
ORCID-Profile: Guixia Liu, Yun Tang, Weihua Li
Förderung
- National Key Research and Development Program of China
- Shanghai Municipal Education Commission
- National Natural Science Foundation of China
Zitieren
APA
Li, L., Lu, Z., Liu, G., Tang, Y., & Li, W. (2023). Machine Learning Models to Predict Cytochrome P450 2B6 Inhibitors and Substrates. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.3c00065
Vancouver
Li L, Lu Z, Liu G, Tang Y, Li W. Machine Learning Models to Predict Cytochrome P450 2B6 Inhibitors and Substrates. Chemical Research in Toxicology. 2023. doi:10.1021/acs.chemrestox.3c00065
BibTeX
@article{Li2023,
author = {Li, Longqiang and Lu, Zhou and Liu, Guixia and Tang, Yun and Li, Weihua},
title = {Machine Learning Models to Predict Cytochrome P450 2B6 Inhibitors and Substrates},
journal = {Chemical Research in Toxicology},
year = {2023},
doi = {10.1021/acs.chemrestox.3c00065}
}
EUVIMED